BCAT1 and colorectal carcinoma: By estimating the true- and false-positive rates of the two-marker blood test for screen-relevant stages of colorectal neoplasia, we have been able to determine that a blood test detecting methylated BCAT1 and IKZF1 DNA facilitates identification of cases with CRC relative to other clinical states encountered in the colon and rectum.